CIP2A/p90 Autoantigen Polyclonal Antibody, Cy5 Conjugated
Product Specifications
Background
Oncoprotein that inhibits PP2A and stabilizes MYC in human malignancies. Promotes anchorage-independent cell growth and tumor formation.
Synonyms
P90; CIP2A; Protein CIP2A; Cancerous inhibitor of PP2A; p90 autoantigen; KIAA1524
Gene ID
57650
Swiss Prot
Q8TCG1
Cellular Locus
Cytoplasm, Cell membrane
Host
Rabbit
Cross Reactivity
Human
Immunogen
601-700/905
Target
CIP2A/p90 Autoantigen
Clonality
Polyclonal
Isotype
IgG
Conjugation
Cy5
Source
KLH conjugated synthetic peptide derived from human CIP2A/p90 Autoantigen
Applications
WB
Purification
Purified by Protein A.
Excitation Emission
625,650nm/670nm
Concentration
1µg/µl
Dilution
WB (1:300-5000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
57650
Predicted Cross Reactivity
Mouse, Rat, Dog, Cow, Rabbit
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740226-100 1x 100 µL
Pmel17 / gp100 / SILV (NKI-beteb), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC700977-100 1x 100 µL
TGF-beta (1D11.16.8), CF770 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680806-100 1x 100 µL
TYRP1 (Tyrosinase Related Protein 1) (TA99), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740835-100 1x 100 µL
Cytokeratin 18 (KRT18/835), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details